Loading...
Loading...
India accounts for a significant share of global Esomeprazole exports, with 643+ registered manufacturers shipping to buyers across 147+ countries — yet a handful of companies dominate the shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest share at 21.8% (export value: $99.5M). Close behind, CIPLA LIMITED (12.8%, $58.3M). MYLAN LABORATORIES LIMITED (6.8%, $31.2M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
Comprehensive supplier network intelligence dashboard
Flow of Esomeprazole from leading Indian exporters to their key global customers
Top Suppliers → Customer Networks
The Esomeprazole export market from India is led by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone commands a 21.8% share, shipping $99.5M worth of product across 1.6K shipments. The second-largest exporter, CIPLA LIMITED, contributes $58.3M (12.8%) to the overall market. Combined, the top two suppliers alone account for 34.6% of all Esomeprazole exports, indicating a relatively concentrated supply base.
Across all 643 tracked manufacturers, the total Esomeprazole export value stands at $456.5M from 9.5K shipments. The market average shipment value is $47.9K. The single largest buyer relationship in terms of trade value is SUN PHARMA CANADA INC, receiving $54.6M worth of product.
The combined buyer network spans 24 named purchasing companies, including SUN PHARMA CANADA INC, YUSEN LOGISTICS BENELUX, M/S. SUN PHARMA ANZ PTY LTD, SUN PHARMA ANZ PTY LTD, EUROFARMA LABORAT?RIOS S/A and 19 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Esomeprazole exporter from India, with a market share of 21.8% and a total export value of $99.5M across 1.6K shipments. Their average shipment value of $60.4K is above the market average of $47.9K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. SUN PHARMA CANADA INC is the dominant customer, accounting for 54.9% of this supplier's tracked business. Top customers include:
• SUN PHARMA CANADA INC — $54.6M across 905 shipments (54.9% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX — $19.4M across 321 shipments (19.5% of this supplier's total exports)
• M/S. SUN PHARMA ANZ PTY LTD — $14.8M across 244 shipments (14.8% of this supplier's total exports)
• SUN PHARMA ANZ PTY LTD — $5.8M across 96 shipments (5.8% of this supplier's total exports)
• EUROFARMA LABORAT?RIOS S/A — $5.0M across 82 shipments (5.0% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $60.4K is 26% above the market average of $47.9K, consistent with large-order contracts or value-added formulations.
Once Esomeprazole leaves the manufacturing plants of companies like SUN PHARMACEUTICAL INDUSTRIES LIMITED and CIPLA LIMITED, it travels to 5 destination markets with a combined import value of $456.5M. United States absorbs the largest share at 24.4% ($111.5M), followed by Canada (19.6%) and Belgium (16.4%).
In United States — the top destination — named importers include CIPLA USA INC UPS SUPPLY CHAIN SOLU, CIPLA USA INC UPS SUPPLY CHAIN SOL, BIOCON PHARMA INC. In Canada, key buyers are SUN PHARMA CANADA INC., MYLAN PHARMACEUTICALS ULC,, SUN PHARMA CANADA INC.
This geographic spread reflects Esomeprazole's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
Comprehensive geographic market intelligence dashboard
Trade flow of Esomeprazole exports from India — top destination countries and the named companies importing it
Top Countries → Global Importers
United States ranks as the first-largest destination for Esomeprazole imports from India, with a total trade value of $111.5M across 494 shipments — representing a 24.4% share of all Esomeprazole exports. The average shipment value of $225.7K is above the global average of $47.9K, indicating high-value procurement contracts or branded formulations. This market is served by 7 tracked buyers.
Named Esomeprazole importers in United States: CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest buyer, accounting for 42.4% ($47.3M) of this market's total imports.
• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $47.3M (42.4% of United States's total)
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $10.0M (9.0% of United States's total)
• BIOCON PHARMA INC — $7.6M (6.8% of United States's total)
Key Insight: United States's per-shipment average of $225.7K (371% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Esomeprazole imports from India.
Visual overview of India's esomeprazole supply chain network — top suppliers, destinations, pricing, and trade routes
This video covers India's esomeprazole pharmaceutical supply chain network — $456.5M in total trade, 147 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.
Latest developments and market context
Detailed market intelligence for Esomeprazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
CIPLA LIMITED is the second-largest Esomeprazole exporter from India, with a market share of 12.8% and a total export value of $58.3M across 611 shipments. Their average shipment value of $95.4K is above the market average of $47.9K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 5 named buyers in our database. CIPLA USA INC UPS SUPPLY CHAIN SOL is the dominant customer, accounting for 72.8% of this supplier's tracked business. Top customers include:
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $42.4M across 445 shipments (72.8% of this supplier's total exports)
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $10.0M across 105 shipments (17.1% of this supplier's total exports)
• CIPLA KENYA LTD C/O IMPERIAL MANAGE — $4.0M across 42 shipments (6.9% of this supplier's total exports)
• BREATHEFREE LANKA PV — $1.0M across 11 shipments (1.7% of this supplier's total exports)
• CIPLA MALAYSIA SDN B — $840.5K across 9 shipments (1.4% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $95.4K is 99% above the market average of $47.9K, consistent with large-order contracts or value-added formulations.
MYLAN LABORATORIES LIMITED is the third-largest Esomeprazole exporter from India, with a market share of 6.8% and a total export value of $31.2M across 179 shipments. Their average shipment value of $174.6K is above the market average of $47.9K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN PHARMACEUTICALS INC, is the dominant customer, accounting for 78.6% of this supplier's tracked business. Top customers include:
• MYLAN PHARMACEUTICALS INC, — $24.6M across 141 shipments (78.6% of this supplier's total exports)
• MYLAN PHARMACEUTICALS INC, — $3.7M across 21 shipments (11.9% of this supplier's total exports)
• MYLAN PHARMACEUTICALS INC, — $1.4M across 8 shipments (4.5% of this supplier's total exports)
• MYLAN IRELAND C/O AL — $899.1K across 5 shipments (2.9% of this supplier's total exports)
• MYLAN PHARMACEUTICALS INC, — $645.9K across 4 shipments (2.1% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $174.6K is 265% above the market average of $47.9K, consistent with large-order contracts or value-added formulations.
MICRO LABS LIMITED is the fourth-largest Esomeprazole exporter from India, with a market share of 6.0% and a total export value of $27.2M across 409 shipments. Their average shipment value of $66.6K is above the market average of $47.9K, suggesting premium or bulk contract pricing.
MICRO LABS LIMITED serves 5 named buyers in our database. DELTA IMPORT-EXPORT MEDICAL CO LTD is the dominant customer, accounting for 93.0% of this supplier's tracked business. Top customers include:
• DELTA IMPORT-EXPORT MEDICAL CO LTD — $25.3M across 380 shipments (93.0% of this supplier's total exports)
• HAWKARY PHARMACEUTIC — $539.9K across 8 shipments (2.0% of this supplier's total exports)
• LABOREX UGANDA LIMIT — $510.4K across 8 shipments (1.9% of this supplier's total exports)
• MICRO NOVA PHARMACEU — $489.5K across 7 shipments (1.8% of this supplier's total exports)
• M/S LABOREX KENYA LI — $374.8K across 6 shipments (1.4% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED's per-shipment value of $66.6K is 39% above the market average of $47.9K, consistent with large-order contracts or value-added formulations.
DR.REDDY'S LABORATORIES LTD is the fifth-largest Esomeprazole exporter from India, with a market share of 1.2% and a total export value of $5.4M across 273 shipments. Their average shipment value of $19.7K is below the market average of $47.9K, reflecting a high-volume, competitive pricing strategy.
DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• DR. REDDYS LABORATORIES, INC — $1.5M across 76 shipments (28.0% of this supplier's total exports)
• NORTHSTAR DISTRIBUTI — $1.4M across 71 shipments (26.1% of this supplier's total exports)
• SIEGFRIED RHEIN S.A. — $1.0M across 52 shipments (19.0% of this supplier's total exports)
• DR. REDDYS LABORATORIES, INC — $751.9K across 38 shipments (14.0% of this supplier's total exports)
• DR. REDDYS LABORATORIES, INC — $694.6K across 35 shipments (12.9% of this supplier's total exports)
Key Insight: DR.REDDY'S LABORATORIES LTD operates with high shipment frequency (273 shipments) at a per-shipment value of $19.7K, indicating a broad distribution network with many smaller, regular orders.
TORRENT PHARMACEUTICALS LTD is the fifth-largest Esomeprazole exporter from India, with a market share of 1.1% and a total export value of $5.0M across 259 shipments. Their average shipment value of $19.2K is below the market average of $47.9K, reflecting a high-volume, competitive pricing strategy.
TORRENT PHARMACEUTICALS LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TORRENT PHARMA INC, — $1.8M across 94 shipments (36.3% of this supplier's total exports)
• TORRENT PHARMA (UK) — $1.2M across 61 shipments (23.4% of this supplier's total exports)
• HATTON NATIONAL BANK — $790.8K across 41 shipments (15.9% of this supplier's total exports)
• GENERICON PHARMA GMB — $744.4K across 39 shipments (15.0% of this supplier's total exports)
• DKSH MALAYSIA SDN BH — $469.0K across 24 shipments (9.4% of this supplier's total exports)
Key Insight: TORRENT PHARMACEUTICALS LTD operates with high shipment frequency (259 shipments) at a per-shipment value of $19.2K, indicating a broad distribution network with many smaller, regular orders.
Canada ranks as the second-largest destination for Esomeprazole imports from India, with a total trade value of $89.6M across 98 shipments — representing a 19.6% share of all Esomeprazole exports. The average shipment value of $914.3K is above the global average of $47.9K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Esomeprazole importers in Canada: SUN PHARMA CANADA INC. is the largest buyer, accounting for 61.0% ($54.6M) of this market's total imports.
• SUN PHARMA CANADA INC. — $54.6M (61.0% of Canada's total)
• MYLAN PHARMACEUTICALS ULC, — $24.8M (27.6% of Canada's total)
• SUN PHARMA CANADA INC — $3.8M (4.2% of Canada's total)
Key Insight: Canada's per-shipment average of $914.3K (1809% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Esomeprazole imports from India.
Belgium ranks as the third-largest destination for Esomeprazole imports from India, with a total trade value of $74.8M across 718 shipments — representing a 16.4% share of all Esomeprazole exports. The average shipment value of $104.1K is above the global average of $47.9K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Esomeprazole importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 86.9% ($64.9M) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $64.9M (86.9% of Belgium's total)
• YUSEN LOGISTICS BENELUX — $9.4M (12.5% of Belgium's total)
Key Insight: Belgium's per-shipment average of $104.1K (117% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Esomeprazole imports from India.
Vietnam ranks as the fourth-largest destination for Esomeprazole imports from India, with a total trade value of $29.6M across 7 shipments — representing a 6.5% share of all Esomeprazole exports. The average shipment value of $4.2M is above the global average of $47.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Esomeprazole importers in Vietnam: DELTA IMPORT-EXPORT MEDICAL CO LTD is the largest buyer, accounting for 86.0% ($25.5M) of this market's total imports.
• DELTA IMPORT-EXPORT MEDICAL CO LTD — $25.5M (86.0% of Vietnam's total)
Key Insight: Vietnam's per-shipment average of $4.2M (8744% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Vietnam is a key market for Esomeprazole imports from India.
Australia ranks as the fifth-largest destination for Esomeprazole imports from India, with a total trade value of $29.5M across 341 shipments — representing a 6.5% share of all Esomeprazole exports. The average shipment value of $86.5K is above the global average of $47.9K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Esomeprazole importers in Australia: M/S. SUN PHARMA ANZ PTY LTD is the largest buyer, accounting for 56.1% ($16.5M) of this market's total imports.
• M/S. SUN PHARMA ANZ PTY LTD — $16.5M (56.1% of Australia's total)
• SUN PHARMA ANZ PTY LTD. — $7.9M (26.7% of Australia's total)
• SUN PHARMA ANZ PTY LTD — $3.0M (10.1% of Australia's total)
Key Insight: Australia's per-shipment average of $86.5K (81% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Esomeprazole imports from India.
Top supplier: 5 customers
6 suppliers → 147 countries
Network value: $456.5M
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9,532 Verified Shipments
643 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists